A new framework for evaluating the health impacts of treatment for Gaucher disease type 1
Crossref DOI link: https://doi.org/10.1186/s13023-017-0592-6
Published Online: 2017-02-20
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ganz, Michael L.
Stern, Sean
Ward, Alex
Nalysnyk, Luba
Selzer, Martin
Hamed, Alaa
Weinreb, Neal
Funding for this research was provided by:
Sanofi Genzyme (N/A)
